Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population

Department of Psychiatry, University of Tartu, Raja 31, 50417, Tartu, Estonia.
BMC Neurology (Impact Factor: 2.04). 04/2005; 5(1):5. DOI: 10.1186/1471-2377-5-5
Source: PubMed


Simpson-Angus Scale (SAS) is an established instrument for neuroleptic-induced parkinsonism (NIP), but its statistical properties have been studied insufficiently. Some shortcomings concerning its content have been suggested as well. According to a recent report, the widely used SAS mean score cut-off value 0.3 of for NIP detection may be too low. Our aim was to evaluate SAS against DSM-IV diagnostic criteria for NIP and objective motor assessment (actometry).
Ninety-nine chronic institutionalised schizophrenia patients were evaluated during the same interview by standardised actometric recording and SAS. The diagnosis of NIP was based on DSM-IV criteria. Internal consistency measured by Cronbach's alpha, convergence to actometry and the capacity for NIP case detection were assessed.
Cronbach's alpha for the scale was 0.79. SAS discriminated between DSM-IV NIP and non-NIP patients. The actometric findings did not correlate with SAS. ROC-analysis yielded a good case detection power for SAS mean score. The optimal threshold value of SAS mean score was between 0.65 and 0.95, i.e. clearly higher than previously suggested threshold value.
We conclude that SAS seems a reliable and valid instrument. The previously commonly used cut-off mean score of 0.3 has been too low resulting in low specificity, and we suggest a new cut-off value of 0.65, whereby specificity could be doubled without loosing sensitivity.

Download full-text


Available from: Kristian Wahlbeck,
  • Source
    • "Anhedonia was measured using the Physical and Social Anhedonia Scale [25]. To identify clinical symptoms and antipsychotics-induced Parkinsonian symptoms of patients, the Positive and Negative Syndrome Scale (PANSS) [26] and Simpson-Angus Scale (SAS) [27] were employed. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Effective integration of visual information is necessary to utilize abstract thinking, but patients with schizophrenia have slow eye movement and usually explore limited visual information. This study examines the relationship between abstract thinking ability and the pattern of eye gaze in patients with schizophrenia using a novel theme identification task. Twenty patients with schizophrenia and 22 healthy controls completed the theme identification task, in which subjects selected which word, out of a set of provided words, best described the theme of a picture. Eye gaze while performing the task was recorded by the eye tracker. Patients exhibited a significantly lower correct rate for theme identification and lesser fixation and saccade counts than controls. The correct rate was significantly correlated with the fixation count in patients, but not in controls. Patients with schizophrenia showed impaired abstract thinking and decreased quality of gaze, which were positively associated with each other. Theme identification and eye gaze appear to be useful as tools for the objective measurement of abstract thinking in patients with schizophrenia.
    Behavioral and Brain Functions 04/2014; 10(1):13. DOI:10.1186/1744-9081-10-13 · 1.97 Impact Factor
  • Source
    • "Drug-related extrapyramidal side effects (EPS) were assessed using Simpson Angus Scale (SAS) [48], Barnes Akathisia Rating Scale (BARS) [49], and Abnormal Involuntary Movement Scale (AIMS) [50]. The diagnostic threshold scores for the presence of pseudoparkinsonism and akathisia were ≥7 in SAS [51] and ≥2 in BARS global clinical assessment item [49], respectively. A score of 3 or more on any of the first 7 AIMS items, or a score of 2 or more on any two of the first 7 AIMS items, was taken to be indicative of dyskinesia [52]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate the prevalence rate of cigarette smoking and its socio-demographic and clinical correlates in Chinese schizophrenia inpatients receiving antipsychotic mono-therapy. This study was a cross-sectional, two-site, hospital-based survey. Four hundred and twenty-nine schizophrenia patients (male/female: 66.9% vs. 33.1%) were consecutively recruited from psychosis inpatient wards of two large specialty psychiatric hospitals in mainland China. Patients were assessed using a cigarette smoking questionnaire, the Positive and Negative Symptom Scale, the Simpson Angus Scale, the Barnes Akathisia Rating Scale, and the Abnormal Involuntary Movement Scale. Socio-demographic and other clinical data were also collected. We calculated the prevalence of current smoking in our sample as well as its indirectly standardized prevalence ratio (ISPR) using data from the 2010 Global Adult Tobacco Survey in China. The prevalence rate of current smoking was 40.6% in our sample, and 57.5% in males and 6.3% in females. The ISPRs of all patients, men and women were 1.11(95%CI: 0.95∼1.29), 1.07(95%CI = 0.91∼1.24) and 4.64(95%CI = 2.12∼8.82), respectively. The overall and male-specific prevalence of current smoking did not differ significantly between patients and the general population. In multiple logistic regression analysis, male sex, older age, poor marital status, alcohol use, use of first-generation antipsychotics, longer duration of illness, more frequent hospitalizations, and more severe negative symptoms were independently associated with current smoking. Male Chinese inpatients with schizophrenia who received a mono-therapy of antipsychotics were not more likely to smoke than the general population. Cigarette smoking is more common in schizophrenia patients with more severe illness.
    PLoS ONE 02/2014; 9(2):e88478. DOI:10.1371/journal.pone.0088478 · 3.23 Impact Factor
  • Source
    • "In order to describe psychopathological features related with schizophrenia, patients were administered a variety of tests: scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1984a), Scale for the Assessment of Positive Symptoms (SAPS; Andreasen, 1984b), Social Anhedonia Scale (SAS; Chapman et al., 1976), Physical Anhedonia Scale (PAS; Chapman et al., 1976). Given that all patients were under medication, we also administered them the Simpson-Angus Extrapyramidal side-effects Scale (Simpson and Angus, 1970), an established, valid and reliable instrument for assessing neuroleptic-induced parkinsonism (Janno et al., 2005). None of them were beyond cut-off value, indicating that SZP participants did not show any significant extrapyramidal side-effect related with drugs assumption. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Emotional facial expression is an important low-level mechanism contributing to the experience of empathy, thereby lying at the core of social interaction. Schizophrenia is associated with pervasive social cognitive impairments, including emotional processing of facial expressions. In this study we test a novel paradigm in order to investigate the evaluation of the emotional content of perceived emotions presented through dynamic expressive stimuli, facial mimicry evoked by the same stimuli, and their functional relation. Fifteen healthy controls and 15 patients diagnosed with schizophrenia were presented with stimuli portraying positive (laugh), negative (cry) and neutral (control) emotional stimuli in visual, auditory modalities in isolation, and congruently or incongruently associated. Participants where requested to recognize and quantitatively rate the emotional value of the perceived stimuli, while electromyographic activity of Corrugator and Zygomaticus muscles was recorded. All participants correctly judged the perceived emotional stimuli and prioritized the visual over the auditory modality in identifying the emotion when they were incongruently associated (Audio-Visual Incongruent condition). The neutral emotional stimuli did not evoke any muscle responses and were judged by all participants as emotionally neutral. Control group responded with rapid and congruent mimicry to emotional stimuli, and in Incongruent condition muscle responses were driven by what participants saw rather than by what they heard. Patient group showed a similar pattern only with respect to negative stimuli, whereas showed a lack of or a non-specific Zygomaticus response when positive stimuli were presented. Finally, we found that only patients with reduced facial mimicry (Internalizers) judged both positive and negative emotions as significantly more neutral than controls. The relevance of these findings for studying emotional deficits in schizophrenia is discussed.
    Frontiers in Human Neuroscience 07/2013; 7. DOI:10.3389/fnhum.2013.00368 · 3.63 Impact Factor
Show more